There is broad recognition among public health experts, the White House and congressional leaders that COVID-19 testing is the most critical element of our national response ... Read More
WASHINGTON, D.C — Following the release of the latest Senate legislation in response to the COVID-19 pandemic, ACLA President Julie Khani released the following statement: ... Read More
WASHINGTON, D.C. – Following today’s White House briefing, ACLA President Julie Khani released the following statement: “As the White House pointed out today, commercial labs are ... Read More
WASHINGTON, D.C. — ACLA President Julie Khani today issued the following statement regarding the current stimulus bill under consideration in the Senate: “ACLA members have ... Read More
WASHINGTON, D.C. — As commercial laboratories rapidly extend considerable resources to meet demand for COVID-19 testing, ACLA President Julie Khani sent a letter to congressional ... Read More
WASHINGTON, D.C. – Following the FDA’s actions announced on March 16, ACLA President Julie Khani released the following statement: “The FDA’s guidance released on Saturday, February 29th cleared ... Read More
Commercial capacity is expected to exceed 20,000 tests per day nationwide by end of next week, 280,000 tests per week by April 1. WASHINGTON, D.C. ... Read More
Last Updated March 2023 Recent Updates Letter (March 21, 2022): COVID Relief Funding Letter Blog (March 1, 2022): An Emerging Crisis of Undiagnosed Diseases and ... Read More
